News & Updates

Show Multimedia Only

Does aspirin use improve outcomes in APS patients with arterial thrombosis?

06 Jan 2026 by

The addition of low-dose aspirin to warfarin appears to increase the risk of major bleeding in patients with antiphospholipid syndrome (APS) but falls short in reducing all-cause mortality, according to a study presented at ASH 2025. Likewise, the rates of ischemic stroke and acute myocardial infarction are also higher among aspirin users.

Does aspirin use improve outcomes in APS patients with arterial thrombosis?

06 Jan 2026

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-December-2025

06 Jan 2026

New drug applications approved by US FDA as of 1-15 December 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-December-2025

06 Jan 2026

Original New Drug Application Approvals by US FDA (16-31 December 2025)

06 Jan 2026

New drug applications approved by US FDA as of 16-31 December 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 December 2025)

06 Jan 2026

Rope skipping: Is high better than moderate intensity for cardiorespiratory fitness?

26 Dec 2025

High-intensity interval (HIIE) and moderate-intensity continuous exercises (MICE) using rope skipping are both effective in improving cardiorespiratory fitness (CRF) in young adults, according to a study. Moreover, both strategies are similarly enjoyable.

Rope skipping: Is high better than moderate intensity for cardiorespiratory fitness?

26 Dec 2025

Routine coffee drinking may have BP-lowering effect

25 Dec 2025

Regular coffee consumption appears to be associated with decreases in blood pressure (BP) levels, as according to a Mendelian randomization analysis.

Routine coffee drinking may have BP-lowering effect

25 Dec 2025

Reduced calf, mid-upper arm circumferences flag poor outcomes in CVD

23 Dec 2025

In patients with cardiovascular disease (CVD), reductions in calf and mid-upper arm circumferences are predictive of poor outcomes, according to new research.

Reduced calf, mid-upper arm circumferences flag poor outcomes in CVD

23 Dec 2025

Risk of cardiac events up after RSV infection

18 Dec 2025

Adults who contract respiratory syncytial virus (RSV) infection appear to be at increased risk of cardiovascular events, according to a study.

Risk of cardiac events up after RSV infection

18 Dec 2025

Oral PCSK9 inhibitor lowers LDL-C by up to 60 percent

16 Dec 2025 by

The oral PCSK9 inhibitor enlicitide lowers LDL-cholesterol (LDL-C) levels and other atherogenic lipids in high-risk patients with hypercholesterolaemia, as shown in the CORALreef Lipids study presented at AHA 2025.

Oral PCSK9 inhibitor lowers LDL-C by up to 60 percent

16 Dec 2025

HFrEF outcomes due to Chagas disease no better with sacubitril/valsartan vs enalapril

15 Dec 2025

In the treatment of patients with heart failure with reduced ejection fraction (HFrEF) secondary to Chagas disease, the use of sacubitril/valsartan does not appear to lead to improvements in clinical outcomes compared with enalapril, according to a study.

HFrEF outcomes due to Chagas disease no better with sacubitril/valsartan vs enalapril

15 Dec 2025

Sedentary behaviour tied to arterial stiffness in older adults

15 Dec 2025

A sedentary behaviour appears to contribute to increased arterial stiffness among older adults, suggests a recent study.

Sedentary behaviour tied to arterial stiffness in older adults

15 Dec 2025

News & Updates

Showing Cardiology articles

Showing

Specialty:

Does aspirin use improve outcomes in APS patients with arterial thrombosis?

Does aspirin use improve outcomes in APS patients with arterial thrombosis?

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-December-2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-December-2025

Original New Drug Application Approvals by US FDA (16-31 December 2025)

Original New Drug Application Approvals by US FDA (16-31 December 2025)

Rope skipping: Is high better than moderate intensity for cardiorespiratory fitness?

Rope skipping: Is high better than moderate intensity for cardiorespiratory fitness?

Routine coffee drinking may have BP-lowering effect

Routine coffee drinking may have BP-lowering effect

Reduced calf, mid-upper arm circumferences flag poor outcomes in CVD

Reduced calf, mid-upper arm circumferences flag poor outcomes in CVD

Risk of cardiac events up after RSV infection

Risk of cardiac events up after RSV infection

Oral PCSK9 inhibitor lowers LDL-C by up to 60 percent

Oral PCSK9 inhibitor lowers LDL-C by up to 60 percent

HFrEF outcomes due to Chagas disease no better with sacubitril/valsartan vs enalapril

HFrEF outcomes due to Chagas disease no better with sacubitril/valsartan vs enalapril

Sedentary behaviour tied to arterial stiffness in older adults

Sedentary behaviour tied to arterial stiffness in older adults